@chrissyfarr Pulmonary Critical Care here - busy practicing in ICU and pulmonary medicine, using AI in many facets of my practice and leading efforts to responsibly implement this tech for patient care at bedside. Can certainly speak to the real experience day to day.
i'll now be referring my patients to this helpful instructional video when they ask why they haven't gotten their portable oxygen concentrator yet... 🫠
really cool ML in mechanical vent CDS at @ATSCritCare by @garyweissman but did the model really ever recommend (dare I say it) SIMV…??? 🤣 @PennPulmonary
it takes a lot to put words like this out there into the wild, even more so when it involves questioning your sense of self as a physician after all we've been through... thanks and well done @cameron_baston
I started writing this more than a year ago. I’m in a much better place now, but it felt important to put these words out there, to share what feels unfortunately common.
Thanks @RanaAwdish for making it possible.
Hopefully it’s helpful to read.
https://t.co/n9FniP1Onv
A 42-year-old woman presented to the ED with a 3-day history of shortness of breath, fatigue, and cough productive of thick, yellow-green sputum. She also reported having low-grade fevers and chills. https://t.co/QvmvWqymBS
🔥 Key issues to consider when training AI models in this insightful thread by @garyweissman as we continue to see increasing efforts to integrate AI into healthcare delivery
https://t.co/gjweZYeSBM
💉 Vancomycin + pip–tazo associated with ⬆️risk of creatinine-defined #AKI in critically ill: pseudotoxicity?? No changes in alternative kidney function biomarkers, nor downstream clinical outcomes associated with true AKI.
#FOAMcc
📎 https://t.co/xMJSZGA7mL
⬇️ Visual Abstract
a tour de force, truly game-changing work. congrats to @MariaCBasil 🔥 you are literally the best of us (I still claim you as part of our fellowship class...)
We were interested in immune pathways of coagulation in COVID-19. New studies from @s_apostolidis. Great collaborations with C.Abrams, M.Poncz & N.Meyer. Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19 https://t.co/w03iyV8gPI